A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer

Head and Neck Clinical Trial

Official title:
A Multicenter Phase II Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer

Status Completed

Clinical Trial Summary

The goal of the study is to test a particular combination of drugs and determine their ability to completely eliminate head and neck cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01693718
Study type	Interventional
Source	University of Chicago
Contact
Status	Completed
Phase	Phase 2
Start date	March 2003
Completion date	September 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00661427` - Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer	Phase 2
Completed	`NCT03268993` - Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer	N/A
Recruiting	`NCT00733434` - The Use of Prostaglandin E1 in Head and Neck Microsurgery	Phase 4
Recruiting	`NCT03053310` - Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer